New York, NY -- (SBWIRE) -- 12/31/2013 -- (TechSonian) - PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: ImmunoGen, Inc. (NASDAQ:IMGN), Elbit Imaging Ltd. (NASDAQ:EMITF), Fite Biopharma Ltd (ADR) (NYSEMKT:CANF), National Fuel Gas Company (NYSE:NFG)
ImmunoGen, Inc. (NASDAQ:IMGN) plunged over 1.69% on Monday as it has named David Johnston as Executive Vice President and Chief Financial Officer, effective today, who would report to the company's President and Chief Executive, Daniel Junius.
Should IMGN a Buy or Sell Now? Find Out Here
Elbit Imaging Ltd. (NASDAQ:EMITF) surged over 36.23% on Monday after it released that it has entered into a definitive contract with Israel-based financial group Bank Hapoalim B.M. on the basis of the general terms of agreement that were approved by the company's unsecured financial creditors.
Can EMITF Show a Strong Recovery? Find out in This Research Report
Israel-based Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) declared on Monday after its subsidiary OphthaliX Inc. (OPLI) has released that top-line results of a Phase III study with its licensed drug CF101 for Dry Eye Syndrome did not meet primary efficacy endpoint of complete clearing of corneal staining, as well as the secondary efficacy endpoints.
Where CANF is Headed Exactly? Find out in This Trend Analysis Reports
National Fuel Gas Company (NYSE:NFG) inched down on Monday after it declared that David Smith, Executive Chairman of the Board, has indicated his intention to retire, effective April 1, 2014. Smith will continue to serve as Chairman of the Board.
Is NFG Buy After The Recent Price Movement? Find Out Here
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)